Building Capacity for HIV/AIDS Prevention Trials Research and Clinical Care
A relatively small number of African sites have the clinical and laboratory capacity to design, manage and carry out HIV/AIDS prevention trials.
A relatively small number of African sites have the clinical and laboratory capacity to design, manage and carry out HIV/AIDS prevention trials.
This grant will establish a West African-driven partnership with Canadian and European collaborators to enhance HIV research and carry out clinical trials in Sénégal (Université Cheikh Anta Diop), the Gambia (Medical Research Council) and Guinea B
Healthcare workers are a priority group for HIV prevention trials because they constitute a large relatively healthy group at risk from blood-borne diseases (hepatitis B, HIV/AIDS), as well as tuberculosis and other pathogens.
There is growing recognition that access to timely, accurate and appropriate information can help improve health outcomes.
Making use of information and communication technology (ICT) to ensure equitable access to health services in developing countries is becoming more and more feasible.
Developed in South Africa, simplified tools and training have been shown to improve outcomes for HIV, tuberculosis (TB) and primary care patients, and to enhance staff satisfaction and confidence.
In April 2009, China issued a new round of health sector reform policies aimed at providing a blueprint for universal basic healthcare coverage for all by 2020.
In sub-Saharan Africa, many children die from diarrhea, acute respiratory illness and malaria, despite the fact that there are well recognized, inexpensive and highly effective treatments for these ailments.
The shift from high to low levels of mortality and fertility called the demographic transition occurred over a century ago in the developed world.
Health care across much of the African continent is hampered by meager resources and a growing burden of disease, with HIV/AIDS, tuberculosis (TB) and malaria leading the charge.